Health3 months ago
Pentixapharm Advances Phase 3 Study for Hypertension Treatment
Pentixapharm Holding AG has received encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding its planned Phase 3 PANDA study. The formal written minutes...
